Back to Search
ELLIOT BORDEN, DMD
DMD
Endodontics
NPI: 1831210699Individual
Specialties, Licenses & Credentials
EndodonticsPrimary
Dentist — Endodontics
Code: 1223E0200X
DS17400L(PA)
Research & Publications (20)
Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo.
PMID 19514839·J Interferon Cytokine Res·2009
7-preclinical
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
PMID 18006112·Lung Cancer·2008
3-trial
Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro.
PMID 18937547·J Interferon Cytokine Res·2008
7-preclinical
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
PMID 18235122·J Clin Oncol·2008
3-trial
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
PMID 18955451·J Clin Oncol·2008
3-trial
Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
PMID 17653094·Oncogene·2008
8-other
Interferons at age 50: past, current and future impact on biomedicine.
PMID 18049472·Nat Rev Drug Discov·2007
6-review
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
PMID 17557954·J Clin Oncol·2007
3-trial
Intimal pulmonary artery sarcoma presenting as dyspnea: case report.
PMID 17603895·Int Semin Surg Oncol·2007
8-other
Adult sarcomas: a missed opportunity for sustained cooperative group translational and clinical research.
PMID 17396485·Oncology (Williston Park)·2007
6-review
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action.
PMID 17103170·Cancer Chemother Pharmacol·2007
7-preclinical
Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.
PMID 17339865·Clin Pharmacol Ther·2007
3-trial
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.
PMID 17823654·J Clin Invest·2007
8-other
Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors.
PMID 17103043·Invest New Drugs·2007
3-trial
IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.
PMID 16689662·J Interferon Cytokine Res·2006
7-preclinical
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
PMID 16801630·J Clin Oncol·2006
7-preclinical
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.
PMID 17085652·Clin Cancer Res·2006
3-trial
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2b.
PMID 17115898·J Interferon Cytokine Res·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1050 BALTIMORE PIKE
SPRINGFIELD, PA 19064 - Phone
- (610) 543-2288
Quick Facts
- NPI
- 1831210699
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile